Resident memory T cells, critical components in tumor immunology
Open Access
- 4 September 2018
- journal article
- review article
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 6 (1), 87
- https://doi.org/10.1186/s40425-018-0399-6
Abstract
CD8+ T lymphocytes are the major anti-tumor effector cells. Most cancer immunotherapeutic approaches seek to amplify cytotoxic T lymphocytes (CTL) specific to malignant cells. A recently identified subpopulation of memory CD8+ T cells, named tissue-resident memory T (TRM) cells, persists in peripheral tissues and does not recirculate. This T-cell subset is considered an independent memory T-cell lineage with a specific profile of transcription factors, including Runx3+, Notch+, Hobit+, Blimp1+, BATF+, AHR+, EOMESneg and Tbetlow. It is defined by expression of CD103 (αE(CD103)β7) and CD49a (VLA-1 or α1β1) integrins and C-type lectin CD69, which are most likely involved in retention of TRM cells in non-lymphoid tissues, including solid tumors. CD103 binds to the epithelial cell marker E-cadherin, thereby favoring the location and retention of TRM in epithelial tumor regions in close contact with malignant cells. The CD103-E-cadherin interaction is required for polarized exocytosis of lytic granules, in particular, when ICAM-1 expression on cancer cells is missing, leading to target cell death. TRM cells also express high levels of granzyme B, IFNγ and TNFα, supporting their cytotoxic features. Moreover, the local route of immunization targeting tissue dendritic cells (DC), and the presence of environmental factors (i.e. TGF-β, IL-33 and IL-15), promote differentiation of this T-cell subtype. In both spontaneous tumor models and engrafted tumors, natural TRM cells or cancer-vaccine-induced TRM directly control tumor growth. In line with these results, TRM infiltration into various human cancers, including lung cancer, are correlated with better clinical outcome in both univariate and multivariate analyses independently of CD8+ T cells. TRM cells also predominantly express checkpoint receptors such as PD-1, CTLA-4 and Tim-3. Blockade of PD-1 with neutralizing antibodies on TRM cells isolated from human lung cancer promotes cytolytic activity toward autologous tumor cells. Thus, TRM cells appear to represent important components in tumor immune surveillance. Their induction by cancer vaccines or other immunotherapeutic approaches may be critical for the success of these treatments. Several arguments, such as their close contact with tumor cells, dominant expression of checkpoint receptors and their recognition of cancer cells, strongly suggest that they may be involved in the success of immune checkpoint inhibitors in various cancers.Funding Information
- Institut National Du Cancer (2016-154)
- Labex Immuno-Oncology
- Agence Nationale de la Recherche (ANR-15-CE17-0023-04 (Selectimmuno))
- Association pour la Recherche sur le Cancer (PJA20161204720)
- Gefluc (R15080LL)
- SIRIC CARPEM
This publication has 96 references indexed in Scilit:
- Paxillin Binding to the Cytoplasmic Domain of CD103 Promotes Cell Adhesion and Effector Functions for CD8+ Resident Memory T Cells in TumorsCancer Research, 2017
- CD8+CD103+ Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer PatientsThe Journal of Immunology, 2015
- Antibody-targeted vaccination to lung dendritic cells generates tissue-resident memory CD8 T cells that are highly protective against influenza virus infectionMucosal Immunology, 2015
- The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skinNature Immunology, 2013
- Transforming Growth Factor-β Signaling Controls the Formation and Maintenance of Gut-Resident Memory T Cells by Regulating Migration and RetentionImmunity, 2013
- BATF is required for normal expression of gut-homing receptors by T helper cells in response to retinoic acidThe Journal of Experimental Medicine, 2013
- Intratumoral Induction of CD103 Triggers Tumor-Specific CTL Function and CCR5-Dependent T-Cell RetentionCancer Research, 2009
- αEβ7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosisThe Journal of Experimental Medicine, 2007
- Essential role for CD103 in the T cell–mediated regulation of experimental colitisThe Journal of Experimental Medicine, 2005
- Adhesion of lymphocytes to bladder cancer cells: the role of the α E β 7 integrinCancer Immunology, Immunotherapy, 2002